Search results for "Vitreous hemorrhage"

showing 6 items of 6 documents

INTRAVITREAL BEVACIZUMAB FOR PROLIFERATIVE DIABETIC RETINOPATHY

2017

PURPOSE To evaluate the effects of intravitreal bevacizumab (IVB) on retinal neovascularization in patients with proliferative diabetic retinopathy (PDR). METHODS Retrospective multicenter interventional case series. A chart review was performed of 81 consecutive patients (97 eyes) with retinal neovascularization due to PDR, who received at least 1 IVB injection. RESULTS The mean age of the patients was 55.6 ± 11.6 years. The mean number of IVB injections was 4 ± 2.5 injections (range, 1-8 injections) per eye. The mean interval between IVB applications was 3 ± 7 months. The mean duration of follow-up was 29.6 ± 2 months (range, 24-30 months). Best-corrected visual acuity and optical coheren…

0301 basic medicinemedicine.medical_specialtyVisual acuitygenetic structuresBevacizumabmedicine.medical_treatmentVitrectomy03 medical and health sciences0302 clinical medicineOphthalmologymedicineAdverse effectRetinabusiness.industryRetrospective cohort studyGeneral MedicineDiabetic retinopathymedicine.diseaseeye diseasesOphthalmology030104 developmental biologymedicine.anatomical_structureVitreous hemorrhage030221 ophthalmology & optometrysense organsmedicine.symptombusinessmedicine.drugRetina
researchProduct

Ahmed valve, suture-less implantation: A new approach to an easier technique.

2013

Purpose Tissue adhesives have been used in ophthalmology instead of sutures to minimize the operating time. This case series investigated the effectiveness and safety of use of cyanoacrylate in Ahmed valve implantation through pars plana for refractory glaucoma. Patients and methods Seventeen eyes of 17 patients with refractory glaucoma underwent Ahmed valve scleral suture-less implantation through pars plana with a cyanoacrylate suture of the plate. Refractory glaucoma was defined as intraocular pressure (IOP) ≥ 21 mm Hg with antiglaucoma eye drops, good adherence to treatment, and no previous glaucoma surgery. IOP control and development of complications were evaluated during the follow-u…

Pars planaAdultMalemedicine.medical_specialtyIntraocular pressureTime Factorsgenetic structuresAnterior Chambermedicine.medical_treatmentGlaucomaVitrectomyPilot ProjectsProsthesis ImplantationTonometry OcularPostoperative ComplicationsOphthalmologymedicineGlaucoma surgeryHumansCyanoacrylatesProspective StudiesGlaucoma Drainage ImplantsHyphemaIntraocular PressureAgedAged 80 and overbusiness.industrySuture TechniquesRetinal detachmentGlaucomaMiddle Agedmedicine.diseaseeye diseasesOphthalmologymedicine.anatomical_structureTreatment OutcomeVitreous hemorrhageFemalesense organsbusinessJournal of glaucoma
researchProduct

Pars-Plana-Vitrektomie bei diabetischen Traktionsamotiones mit Foramen

2000

PURPOSE: To evaluate results and prognostic factors of pars-plana vitrectomy (ppv) using membrane peeling and C2F6-gas for diabetic traction retinal detachments with a hole. METHODS: We retrospectively reviewed the healing course of 84 eyes, which were treated in this way consecutively (follow-up 6-32 month). C2F6 was always used in case of a retinal hole at the posterior pole or in the upper part of the eye. The influence of HBA1c, type of diabetes, preoperative visual acuity, preoperative laser-coagulation and macular status over treatment results and rate of complications were studied using multivariate logistic regression analysis. RESULTS: Preoperatively 56% of the eyes showed premacul…

Pars planamedicine.medical_specialtyVisual acuitygenetic structuresbusiness.industrymedicine.medical_treatmentPosterior poleRetinal perforationRetinal detachmentVitrectomyDiabetic retinopathymedicine.diseaseeye diseasesOphthalmologymedicine.anatomical_structureOphthalmologyVitreous hemorrhagemedicinesense organsmedicine.symptombusinessKlinische Monatsblätter für Augenheilkunde
researchProduct

Evaluation of the improvement of sensibility with the new IOL Master software version 5.4.3

2009

Purpose To evaluate the improvement of sensibility of the new IOL-Master version 5.4.3 compared with the version 4.08. Methods 214 eyes of 115 patients were examined in a cataract preoperative evaluation making use of both IOL-Master software versions 5.4.3 and 4.08. The type and severity of the lens opacification was assessed by slitlamp biomicroscopy. Results In 182 of the eyes examined both versions were capable to determine the AL; in 29 the version 4.01 could not determine AL whereas the version 5.4.3 was able to measure it; these cases showed posterior capsular cataract (16), dense nuclear cataract (11), posterior synechiae (1) and asteroid hyalosis (1). Finally, the AL of 3 eyes coul…

Posterior capsular cataractmedicine.medical_specialtyNuclear cataractAsteroid hyalosisbusiness.industryGeneral Medicinemedicine.diseaseOphthalmologyOphthalmologyVitreous hemorrhagemedicineSensibilityPosterior synechiaeBrunescent cataractbusinessActa Ophthalmologica
researchProduct

Incidence and Risk Factors for Tractional Macular Detachment after Anti-Vascular Endothelial Growth Factor Agent Pretreatment before Vitrectomy for C…

2019

The study&rsquo

medicine.medical_specialtyYounger agegenetic structuresmedicine.medical_treatmentvitrectomyVitrectomytractional macular detachmentArticle03 medical and health sciences0302 clinical medicineOphthalmologymedicine030212 general & internal medicineanti-VEGF; proliferative diabetic retinopathy; tractional macular detachment; vitrectomyAnti vegfbusiness.industryPrimary vitrectomyIncidence (epidemiology)General MedicineDiabetic retinopathymedicine.diseaseeye diseasesMacular detachmentanti-VEGFVitreous hemorrhage030221 ophthalmology & optometrysense organsbusinessproliferative diabetic retinopathyJournal of Clinical Medicine
researchProduct

Maintenance of anticoagulant and antiplatelet agents for patients undergoing vitreoretinal surgery

2010

International audience; Purpose: To establish the prevalence of anticoagulant, aspirin, and clopidogrel use in patients undergoing vitreoretinal surgery, and to compare the outcome of peribulbar anesthesia between users and non‐users. Methods: We conducted a retrospective case series in one academic center between January and June 2009. We analyzed the chart of 239 eyes who underwent posterior segment surgery with peribulbar anesthesia. No changes in the anticoagulant regimen were made prior to surgery. We divided patients into 7 groups: group 1: patients with no anticoagulants and 6 groups defined according to the type of anticoagulant or antiplatelet medication. Results: 239 eyes (206 pat…

medicine.medical_specialtygenetic structuresmedicine.drug_classMedicine[SDV.MHEP.OS]Life Sciences [q-bio]/Human health and pathology/Sensory OrgansAspirin[SDV.MHEP] Life Sciences [q-bio]/Human health and pathologybusiness.industryAnticoagulantRetinal detachmentGeneral MedicineDiabetic retinopathyMacular degenerationClopidogrelmedicine.diseaseeye diseases3. Good healthSurgeryOphthalmologyRegimen[SDV.MHEP.OS] Life Sciences [q-bio]/Human health and pathology/Sensory OrgansAnesthesiaVitreous hemorrhagebusiness[SDV.MHEP]Life Sciences [q-bio]/Human health and pathologymedicine.drug
researchProduct